PlainRecalls
FDA Devices Moderate Class II Ongoing

Hemopro 2 with Vasoshield, Model VH-4001

Reported: January 25, 2023 Initiated: December 22, 2022 #Z-0995-2023

Product Description

Hemopro 2 with Vasoshield, Model VH-4001

Reason for Recall

Ink on the Vasoshield syringe Maquet logo may chip resulting in an unreasonable risk of harm to the patient. Potential harms may include foreign body reaction, coronary embolic event, and peripheral embolic event.

Details

Units Affected
9817 devices
Distribution
US Nationwide. Japan, Germany.
Location
Wayne, NJ

Frequently Asked Questions

What product was recalled?
Hemopro 2 with Vasoshield, Model VH-4001. Recalled by Maquet Cardiovascular, LLC. Units affected: 9817 devices.
Why was this product recalled?
Ink on the Vasoshield syringe Maquet logo may chip resulting in an unreasonable risk of harm to the patient. Potential harms may include foreign body reaction, coronary embolic event, and peripheral embolic event.
Which agency issued this recall?
This recall was issued by the FDA Devices on January 25, 2023. Severity: Moderate. Recall number: Z-0995-2023.